Search for: "FEDERAL TRADE COMMISSION" Results 1101 - 1120 of 22,837
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
On January 25, 2024, the Federal Trade Commission (FTC) hosted a summit focused on the impact of artificial intelligence (AI) on consumers and competition in the technology sector. [read post]
7 Mar 2024, 7:06 am by Unknown
Rule 605's reporting is limited to "covered orders," and the definition of that term has been expanded to include certain orders submitted outside of regular trading hours (that become executable after the opening or reopening of trading during regular trading hours), certain orders submitted with stop prices, and non-exempt short sale orders, i.e., those where a short sale price test is not in effect.The amendments change how orders are categorized both by… [read post]
6 Mar 2024, 12:34 pm by Ginger Buck
  Yesterday, the government announced a joint effort between the Department of Justice (DOJ), the Federal Trade Commission (FTC), and the Department of Health and Human Services (HHS), to inquire into “private-equity and other corporations’ increasing control over health care. [read post]
6 Mar 2024, 11:52 am by John Carroll, Joy Siu and Jake Walker
On March 5, 2024, the Federal Trade Commission (“the FTC”) hosted a public workshop titled “Private Capital, Public Impact: An FTC Workshop on Private Equity in Health Care”, which covered the impact of private equity investment on the health care system. [read post]
6 Mar 2024, 5:29 am by Robert Kraft
Additional Resources: National Council on Aging: https://www.ncoa.org/older-adults/money/management/avoiding-scams AARP Fraud Watch Network: https://www.aarp.org/money/scams-fraud/about-fraud-watch-network/ Federal Trade Commission: https://www.ftc.gov/ National Center for Elder Abuse: https://ncea.acl.gov/home Remember, vigilance and open communication are key to protecting ourselves and our loved ones from elder fraud. [read post]
5 Mar 2024, 9:05 pm by renholding
But under these proposals, secondary market trading in cryptoassets could be regulated by the Commodity Futures Trading Commission, by an industry self-regulatory body, by cryptoexchanges acting as self-regulators, or by a combination thereof. [read post]
5 Mar 2024, 6:00 am by Harold Hongju Koh
Law-abiding countries have regularly invoked this doctrine to induce compliance with the rules of aviation, trade, and security. [read post]
5 Mar 2024, 5:00 am by Daniel J. Gilman
In yet another example of interagency cheerleading from the Federal Trade Commission (FTC), Chair Lina Khan recently touted the work of the Consumer Financial Protection Bureau (CFPB) on payments networks: New @CFPB research reveals that large banks are offering worse credit card terms & interest rates than small banks and credit unions, regardless of credit risk. [read post]
Over the past several years, bills of this nature have been proposed by the New York City Council and failed to advance, but with the renewed public interest from the state legislature’s recent attempt at a total ban on non-competes, and the Federal Trade Commission’s upcoming rulemaking, it is possible that the City Council will have greater traction this time around. [read post]
4 Mar 2024, 9:45 am by Dennis Crouch
When competitor Anhui Jinhe began importing Ace-K into the U.S., Celanese sued Jinhe for patent infringement at the International Trade Commission (ITC). [read post]
4 Mar 2024, 4:31 am by Daniel J. Gilman
It was touted most recently in the Federal Trade Commission’s (FTC) comments to the National Institute of Standards and Technology (NIST) in support of expanded march-in rights. [read post]
This trend is not isolated, as seen with California’s stance, where a law imposes civil liability on employers who enter into or attempt to enforce a noncompete agreement, and the Federal Trade Commission’s proposed nationwide ban. [read post]
4 Mar 2024, 2:30 am by Donna Glover, Baker Donelson
The Underlying Case Trevor Murray filed a SOX complaint in federal district court alleging UBS terminated his employment in violation of §1514A. [read post]